Skip to main content

Rabbit Polyclonal FAM49B antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human CYRIB aa 1-150.

Be the first to review this product! Submit a review

Images

Western blot - Anti-FAM49B antibody (AB121299), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-FAM49B antibody (AB121299), expandable thumbnail
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FAM49B antibody (AB121299), expandable thumbnail
  • Western blot - Anti-FAM49B antibody (AB121299), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine)

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Recombinant Fragment Protein within Human CYRIB aa 1-150. The exact immunogen used to generate this antibody is proprietary information. Database link Q9NUQ9

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IHC-PWBICC/IF
Human
Tested
Tested
Tested

Tested
Tested

Species
Human
Dilution info
1/50.00000 - 1/200.00000
Notes

Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Tested
Tested

Species
Human
Dilution info
0.04000-0.40000 µg/mL
Notes

-

Tested
Tested

Species
Human
Dilution info
0.25000-2.00000 µg/mL
Notes

-

Target data

Function

Negatively regulates RAC1 signaling and RAC1-driven cytoskeletal remodeling (PubMed:30250061, PubMed:31285585). Regulates chemotaxis, cell migration and epithelial polarization by controlling the polarity, plasticity, duration and extent of protrusions. Limits Rac1 mediated activation of the Scar/WAVE complex, focuses protrusion signals and regulates pseudopod complexity by inhibiting Scar/WAVE-induced actin polymerization (PubMed:30250061). Protects against Salmonella bacterial infection. Attenuates processes such as macropinocytosis, phagocytosis and cell migration and restrict sopE-mediated bacterial entry (PubMed:31285585). Restricts also infection mediated by Mycobacterium tuberculosis and Listeria monocytogenes (By similarity). Involved in the regulation of mitochondrial dynamics and oxidative stress (PubMed:29059164).

Alternative names

Recommended products

Rabbit Polyclonal FAM49B antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human CYRIB aa 1-150.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Recombinant Fragment Protein within Human CYRIB aa 1-150. The exact immunogen used to generate this antibody is proprietary information. Database link Q9NUQ9
Purification technique
Affinity purification Immunogen
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Western blot - Anti-FAM49B antibody (ab121299), expandable thumbnail

    Western blot - Anti-FAM49B antibody (ab121299)

    All lanes: Western blot - Anti-FAM49B antibody (ab121299) at 1/250 dilution

    Lane 1: RT4 cell lysate

    Lane 2: Human Plasma lysate

    Lane 3: U-251 MG cell lysate

    Lane 4: Human Liver lysate

    Lane 5: Human Tonsil lysate

    Developed using the ECL technique.

    Predicted band size: 37 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-FAM49B antibody (ab121299), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-FAM49B antibody (ab121299)

    Immunofluorescent staining of Human cell line U-2 OS shows positivity in nucleus. Recommended concentration of ab121299 1-4 µg/ml. Cells treated with PFA/Triton X-100.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FAM49B antibody (ab121299), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FAM49B antibody (ab121299)

    ab121299 at 1/100 dilution staining FAM49B in Paraffin-emebedded Human kidney tissue by Immunohistochemistry.

  • Western blot - Anti-FAM49B antibody (ab121299), expandable thumbnail

    Image collected and cropped by CiteAb under a CC-BY license from the publication

    Western blot - Anti-FAM49B antibody (ab121299)

    FAM49B western blot using anti-FAM49B antibody ab121299. Publication image and figure legend from Zhang, Y., Du, P., et al., 2020, Int J Biol Sci, PubMed 32071545.


    ab121299 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab121299 please see the product overview.

    TASP1 regulates FAM49B via the PI3K/AKT signaling pathway. (A) The expression levels of TASP1, phosphorylated PI3K (Tyr607)/total PI3K and phosphorylated AKT (Ser473)/total AKT were determined in Lv-shNC and Lv-shTASP1 groups by western blot. (B-D) Myc-TASP1-transfected GBC cells was treated with 20 μM LY294002 for 12 h. The proliferation and migration abilities were reduced. TASP1, phosphorylated PI3K (Tyr607)/total PI3K, phosphorylated AKT (Ser473)/total AKT and FAM49B expression levels were examined by western blot. GAPDH was used as the loading control. (E) The proposed mechanistic scheme of TASP1 regulating FAM49B by activating PI3K/AKT signaling pathway in GBC.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com